This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 21-27 May 2023 May 2023 and includes updates on COVID-19, influenza, Marburg virus disease, poliomyelitis, extensively drug-resistant Pseudomonas aeruginosa, and suspected fungal meningitis.
Following a peak at week 51/2022, influenza activity had been decreasing across the Region until week 4/2023, before rising again to fluctuate around 25% positivity between weeks 6 and 11/2023 and decreasing below 10% positivity in week 16/2023.
Following a peak at week 51/2022, influenza activity had been decreasing across the Region until week 4/2023 when it reached 21% positivity, before rising again to fluctuate around 25% positivity between weeks 6 and 11/2023 and is coming to an end with positivity falling below the 10% seasonal threshold in week 16/2023 (9%).
Following a peak at week 51/2022, influenza activity had been decreasing across the Region until week 4/2023, before rising again to fluctuate around 25% positivity between weeks 6 and 11/2023 and decreasing below 10% positivity in week 16/2023.
The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 16-22 April 2023 and includes updates on influenza, avian influenza, Marburg virus disease, COVID-19 and poliomyelitis.
Following a peak at week 51/2022, influenza activity had been decreasing across the Region until week 4/2023 before rising again to fluctuate around 25% positivity between weeks 6 and 11/2023 and decreasing again to 10% positivity in week 15/2023.
Following a peak at week 51/2022, influenza activity had been decreasing across the Region until week 4/2023, before rising again to fluctuate around 25% positivity between weeks 6 and 11/2023 and decreasing again to 15% positivity for week 14/2023.
Following a peak at week 51/2022, influenza activity had been decreasing across the Region until week 4/2023 when it reached 22% positivity before rising again to fluctuate around 25% positivity between weeks 6 and 11/2023 before decreasing again to 22% positivity in week 12/2023.
